Cadmium-induced hypertension in rats

Area of Science:

• Toxicology
• Cardiovascular Pharmacology
• Environmental Health

Background:

• Cadmium chloride (CdCl2) is an environmental toxin.
• Hypertension is a significant global health concern.
• The mechanisms underlying cadmium-induced hypertension require further elucidation.

Purpose of the Study:

• To investigate the effects of chronic cadmium chloride administration on blood pressure in rats.
• To explore the potential mechanisms involved in cadmium-induced hypertension.
• To assess the efficacy of calcium channel blockers in preventing cadmium-induced hypertension.

Main Methods:

• Female albino rats were treated with varying doses of cadmium chloride (0.5 and 1.0 mg/kg) intraperitoneally for two weeks.
• Cardiovascular responses to vasoactive agents (noradrenaline, angiotensin II, acetylcholine, isoprenaline) were evaluated.
• Rat hindquarter preparations were used to assess vascular sensitivity.
• The impact of adrenalectomy, sympathectomy, captopril, verapamil, and nifedipine on cadmium-induced hypertension was examined.

Main Results:

• Chronic cadmium chloride treatment led to a significant elevation in blood pressure.
• Pressor and depressor responses to various vasoactive agents remained largely unaltered.
• Increased perfusion pressure and enhanced noradrenaline sensitivity were observed in the hindquarter vascular bed.
• Adrenalectomy, sympathectomy, and captopril did not prevent hypertension development.
• Verapamil and nifedipine effectively prevented the rise in blood pressure.

Conclusions:

• Chronic cadmium chloride exposure induces hypertension in rats.
• Cadmium may exert its hypertensive effects by mimicking calcium ions, leading to altered vascular tone.
• Calcium channel blockers represent a potential therapeutic strategy against cadmium-induced hypertension.